Lord, Abbett & Co
NXTC icon

Lord, Abbett & Co’s NextCure NXTC Stock Holding History

Lord, Abbett & Co’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-147,012
Closed -$37.8M – 667
2020
Q2 		$37.8M Sell
147,012
-31,100
-17% -$11.8M 0.13% 251
2020
Q1 		$79.2M Buy
178,112
+57,920
+48% +$30.9M 0.35% 78
2019
Q4 		$81.2M Buy
120,192
+78,803
+190% +$39.5M 0.27% 108
2019
Q3 		$15.3M Buy
+41,389
New +$13.5M 0.05% 457

Other funds holding NXTC

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2B AUM 117.41% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return